Industry·August 21, 2026

Mark Cuban Discusses Pricing Transparency and Cost Plus Drug Company Model

Mark Cuban, founder of Cost Plus Drug Company, discussed healthcare pricing transparency and his approach to generic drug pricing in an interview with KFF Health News. Cuban's online pharmacy model focuses on transparent pricing for generic drugs. The discussion covers his views on broader healthcare system reform and price disclosure. The interview addresses how his direct-to-consumer pharmacy model differs from traditional pharmacy benefit manager arrangements.

Why it matters

Cost Plus Drug Company's pricing model represents an alternative to traditional PBM arrangements that some Medicaid managed care plans and state pharmacy programs may evaluate for generic drug procurement.

Pharmacy · Managed Care

Read the full article at kffhealthnews.org →

Share this briefing